EP3383385
Melflúfen-skammtaáætlanir fyrir krabbamein
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
1.12.2016EP published:
29.7.2020EP application number:
16805792.5
EP translation filed:
13.10.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
30.11.2036Expiry date:
30.11.2025Next due date:
30.12.2025
Title:
MELFLUFEN DOSAGE REGIMENS FOR CANCER
Timeline
Today
1.12.2016EP application
29.7.2020EP Publication
13.10.2020Translation submitted
15.11.2020Registration published
30.11.2025Expires
Owner
Name:
Oncopeptides Innovation ABAddress:
Luntmakargatan 46, 111 37 Stockholm, SE
Inventor
Name:
LINDBERG, JakobAddress:
S-111 53 Stockholm, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201521217Date:
1.12.2015Country:
GB
Classification
Categories:
A61K 31/223, A61K 31/573
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 6.11.2020
Expires: 30.11.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 8.11.2021
Expires: 30.11.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 9.11.2022
Expires: 30.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 15.11.2023
Expires: 30.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.11.2024
Expires: 30.11.2025
Payer: Árnason Faktor ehf.